Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group

Renée L. Mulder, Anna Font-Gonzalez, Eline van Dulmen-den Broeder, Gwendolyn P. Quinn, Jill P. Ginsberg, Erik A.H. Loeffen, Melissa M. Hudson, Karen C. Burns, Hanneke M. van Santen, Claire Berger, Tamara Diesch, Uta Dirksen, Aleksander Giwercman, Clarisa Gracia, Sarah E. Hunter, Joanne F. Kelvin, James L. Klosky, Joop S.E. Laven, Barbara A. Lockart, Sebastian J.C.M.M. NeggersMichelle Peate, Bob Phillips, Damon R. Reed, Eva Maria E. Tinner, Julianne Byrne, Margreet Veening, Marleen van de Berg, Chris M. Verhaak, Antoinette Anazodo, Kenny Rodriguez-Wallberg, Marry M. van den Heuvel-Eibrink, Ogechukwu A. Asogwa, Alexandra Brownsdon, W. Hamish Wallace, Daniel M. Green, Roderick Skinner, Riccardo Haupt, Lisa B. Kenney, Jennifer Levine, Marianne D. van de Wetering, Wim J.E. Tissing, Norbert W. Paul, Leontien C.M. Kremer, Julia Inthorn, PanCareLIFE Consortium

Forskningsoutput: TidskriftsbidragÖversiktsartikelPeer review

Sammanfattning

Patients with childhood, adolescent, and young adult cancer who will be treated with gonadotoxic therapies are at increased risk for infertility. Many patients and their families desire biological children but effective communication about treatment-related infertility risk and procedures for fertility preservation does not always happen. The PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group reviewed the literature and developed a clinical practice guideline that provides recommendations for ongoing communication methods for fertility preservation for patients who were diagnosed with childhood, adolescent, and young adult cancer at age 25 years or younger and their families. Moreover, the guideline panel formulated considerations of the ethical implications that are associated with these procedures. Grading of Recommendations Assessment, Development and Evaluation methodology was used to grade the evidence and recommendations. In this clinical practice guideline, existing evidence and international expertise are combined to develop transparent recommendations that are easy to use to facilitate ongoing communication between health-care providers and patients with childhood, adolescent, and young adult cancer who might be at high risk for fertility impairment and their families.

Originalspråkengelska
Sidor (från-till)e68-e80
TidskriftThe Lancet Oncology
Volym22
Nummer2
DOI
StatusPublished - 2021

Ämnesklassifikation (UKÄ)

  • Cancer och onkologi

Fingeravtryck

Utforska forskningsämnen för ”Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här